Luvira
Product Images NDC 69336-349

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Luvira (NDC 69336-349). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sterling-knight Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Luvira (Luvira)

Luvira is a dietary supplement that contains 1.22g omega-3-acid liquid concentrate per capsule, with a total of 840mg omega-3 fatty acids, of which 465mg is Eicosapentaenoic acid (EPA) and 375mg is Docosahexaenoic acid (DHA). It is recommended to take 3-4 capsules per day, to be swallowed whole, without breaking, crushing or chewing. Luvira should be kept at a controlled room temperature of 25°C (77°F), with excursions allowed between 15°C-30°C (69°F-86°F), and should not be frozen. The product must not be accepted if the seal on the bottle opening is missing or broken. Luvira should be taken under the supervision of a licensed medical practitioner and kept out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.